Q1 2024 Holdings
Filed 2024-05-15 | 62 holdings | $3.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $1.1B | 21,751,284 | 30.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $207.5M | 5,161,801 | 5.7% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $192.8M | 5,981,212 | 5.3% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $125.0M | 3,922,413 | 3.4% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $110.9M | 10,400,158 | 3.0% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $109.9M | 2,919,818 | 3.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $109.8M | 4,370,024 | 3.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $108.7M | 3,755,990 | 3.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $105.3M | 2,428,613 | 2.9% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $103.4M | 9,135,893 | 2.8% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $102.1M | 4,786,293 | 2.8% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $87.4M | 3,633,743 | 2.4% |
| CG Oncology Inc(CGON) | COM | 156944100 | $82.7M | 1,884,191 | 2.3% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $76.4M | 4,661,194 | 2.1% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $74.3M | 8,748,629 | 2.0% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $61.8M | 5,870,000 | 1.7% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $60.0M | 1,863,809 | 1.6% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $54.5M | 3,196,701 | 1.5% |
| Merus N V | COM | N5749R100 | $52.8M | 1,172,249 | 1.5% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $51.0M | 1,162,306 | 1.4% |
| Annexon Inc(ANNX) | COM | 03589W102 | $50.2M | 7,000,000 | 1.4% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $48.7M | 10,333,600 | 1.3% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $47.1M | 4,047,354 | 1.3% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $44.6M | 1,875,000 | 1.2% |
| AC Immune SA(ACIU) | SHS | H00263105 | $43.1M | 14,571,236 | 1.2% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $41.2M | 4,365,933 | 1.1% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $38.2M | 2,251,037 | 1.0% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $36.0M | 1,521,948 | 1.0% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $34.8M | 812,988 | 1.0% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $28.9M | 2,742,409 | 0.8% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $28.6M | 9,544,262 | 0.8% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $23.7M | 2,989,474 | 0.7% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $20.9M | 16,552,417 | 0.6% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $19.9M | 1,685,219 | 0.5% |
| Calliditas Therapeutics AB | SPONSERED ADS | 13124Q106 | $16.2M | 750,000 | 0.4% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $14.4M | 6,595,801 | 0.4% |
| Elevation Oncology Inc | COM | 28623U101 | $11.9M | 2,312,200 | 0.3% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $11.8M | 3,853,818 | 0.3% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $11.8M | 8,902,972 | 0.3% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $10.6M | 2,000,000 | 0.3% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $8.9M | 4,326,710 | 0.2% |
| Verve Therapeutics Inc | COM | 92539P101 | $8.6M | 650,000 | 0.2% |
| Ikena Oncology Inc | COM | 45175G108 | $6.8M | 4,769,164 | 0.2% |
| Cidara Therapeutics Inc | COM | 171757107 | $6.3M | 6,861,127 | 0.2% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $6.2M | 1,813,633 | 0.2% |
| Delcath SYS Inc(DCTH) | COM NEW | 24661P807 | $5.7M | 1,202,067 | 0.2% |
| Unicycive Therapeutics Inc | COM | 90466Y103 | $5.0M | 3,611,601 | 0.1% |
| Engene Holdings Inc(ENGNW) | *W EXP 10/31/202 | 29286M113 | $4.9M | 945,402 | 0.1% |
| SAB Biotherapeutics Inc(SABS) | COM NEW | 78397T202 | $4.2M | 917,826 | 0.1% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $4.0M | 1,686,924 | 0.1% |